Pure Global AI
Authorised representative profile

AMO Asia Limited

Hong Kong MDACS94 represented devices14 applicantsAug 22, 2007 – Oct 16, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
94
Total devices
14
Applicants
2007
First representation
2024
Most recent
AR overview
Authorised representative (EN)
AMO Asia Limited
Phone
24803330
Timeline
First representation
Aug 22, 2007
Most recent
Oct 16, 2024
Regulatory footprint
Search AMO Asia Limited across other regulatory registries
Risk class distribution
II10
III77
IV7
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by AMO Asia Limited
Cataract Extraction Phacoemulsification/Vitrectomy Systems
白内障摘除超声乳化术/玻璃体切除术系统
Oct 16, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, Inc.Johnson & Johnson Medtech
Lasers, Femtosecond Pulse
激光,飞秒脉冲
Oct 16, 2024
Risk class
III
Applicant
AMO Manufacturing USA, LLC.Amo Manufacturing Usa, Llc
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
Sep 02, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, IncJohnson & Johnson Medtech
Viscoelastic Solutions, Intraocular
粘弹性解决方案,眼内
Aug 16, 2024
Risk class
III
Applicant
AMO Uppsala ABAmo Uppsala Ab
Viscoelastic Solutions, Intraocular
粘弹性解决方案,眼内
Aug 16, 2024
Risk class
III
Applicant
AMO Uppsala ABAmo Uppsala Ab
Viscoelastic Solutions, Intraocular
粘弹性解决方案,眼内
Aug 16, 2024
Risk class
III
Applicant
AMO Uppsala ABAmo Uppsala Ab
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
Aug 08, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, IncJohnson & Johnson Medtech
Cleaning Solutions, Contact Lens
清洁溶液,隐形眼镜
Aug 08, 2024
Risk class
III
Applicant
AMO IrelandAmo Ireland
Cataract Extraction Phacoemulsification/Vitrectomy Systems
白内障摘除超声乳化术/玻璃体切除术系统
Aug 08, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, Inc.Johnson & Johnson Medtech
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
Jun 24, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, Inc.Johnson & Johnson Medtech
Thermal/Pressure Pulsatile Therapy Units, Meibomian Gland
热/压力脉冲治疗装置,睑板腺
Jun 24, 2024
Risk class
II
Applicant
TearScience Inc.Tearscience,Inc.
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
Jun 24, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, IncJohnson & Johnson Medtech
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
Apr 30, 2024
Risk class
III
Applicant
Johnson & Johnson Surgical Vision, Inc.Johnson & Johnson Medtech
Cleaning Solutions, Contact Lens
清洁溶液,隐形眼镜
Apr 30, 2024
Risk class
III
Applicant
AMO IrelandAmo Ireland
Lasers, Femtosecond Pulse
激光,飞秒脉冲
Apr 30, 2024
Risk class
III
Applicant
AMO Manufacturing USA, LLCAmo Manufacturing Usa, Llc
About this profile

AMO Asia Limited serves as the authorised representative for 94 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.